Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dariusz Pawlak

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Nephron. Physiology|May 4, 2004
Oxidative stress influences CC-chemokine levels in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 31, 2006
Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patientsKrystyna Pawlak, Dariusz Pawlak, Michał Myśliwiec
Atherosclerosis|March 3, 2006
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Cytokine|September 11, 2007
Chronic viral hepatitis and iron affect the plasma levels of LIGHT--a new member of the TNF superfamily in uraemic haemodialyzed patientsKrystyna Pawlak, Michal Mysliwiec, Dariusz Pawlak
Thrombosis Research|July 11, 2006
Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activityKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Thrombosis Research|March 30, 2007
Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Thrombosis Research|August 21, 2007
Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patientsKrystyna Pawlak, Dariusz Pawlak, Michal Myśliwiec
Clinical Biochemistry|April 26, 2011
Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysisKrystyna Pawlak, Michal Mysliwiec, Dariusz Pawlak
International Journal of Molecular Sciences|July 2, 2021
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular SignalingKrystyna Pawlak, Beata Sieklucka, Dariusz Pawlak
International Journal of Tryptophan Research : IJTR|February 25, 2022
Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?Adrian Mor, Bartlomiej Kalaska, Dariusz Pawlak
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Nephron. Physiology|May 4, 2004
Oxidative stress influences CC-chemokine levels in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 31, 2006
Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patientsKrystyna Pawlak, Dariusz Pawlak, Michał Myśliwiec
Atherosclerosis|March 3, 2006
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Cytokine|September 11, 2007
Chronic viral hepatitis and iron affect the plasma levels of LIGHT--a new member of the TNF superfamily in uraemic haemodialyzed patientsKrystyna Pawlak, Michal Mysliwiec, Dariusz Pawlak
Thrombosis Research|July 11, 2006
Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activityKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Thrombosis Research|March 30, 2007
Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal Mysliwiec
Thrombosis Research|August 21, 2007
Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patientsKrystyna Pawlak, Dariusz Pawlak, Michal Myśliwiec
Clinical Biochemistry|April 26, 2011
Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysisKrystyna Pawlak, Michal Mysliwiec, Dariusz Pawlak
International Journal of Molecular Sciences|July 2, 2021
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular SignalingKrystyna Pawlak, Beata Sieklucka, Dariusz Pawlak
International Journal of Tryptophan Research : IJTR|February 25, 2022
Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?Adrian Mor, Bartlomiej Kalaska, Dariusz Pawlak
Pageof 22